
Library Catalogue

| 000 -LEADER | |
|---|---|
| fixed length control field | 01874nam a2200145Ia 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260209120130.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 260209s9999||||xx |||||||||||||| ||und|| |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Priya Vijay |
| 245 #0 - TITLE STATEMENT | |
| Title | Competition issues in the pharmaceutical sector and right to access to medicine |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | BangaloreBangalore |
| Name of publisher, distributor, etc. | NLSIU |
| Date of publication, distribution, etc. | 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 114 p. ; 25 cm. |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Table of Contents Backdrop of the study; Chapter One ; Pharmaceutical sector and Competition: different aspects ; History of pharmaceutical sector in India; II) Why to be regulated; II. Competition in Pharma sector and poverty and role of government; Advantages of Competition regime; Object of regulatory Control; Drug pricing & Competition; Chapter Two ; Regulatory Framework of the Pharmaceutical Sector ; Relevant legislations Rules ; Some Relevant policies ; Regulatory agencies ; Chapter Three ; Competition Issues in Pharmaceutical sector ; STATUTORY PROVISIONS: Anti-competitive agreements and collusive practices ; Cartel- ; Abuse of dominance ; Regulation of Combination; Chapter Four ; Merger & Acquisitions of Pharm a Companies ; Incentives for Mergers and Acquisitions by Indian companies ; Sun Pharmaceuticals Industries/Taro Pharmaceutical Industries ; Mylan Laboratories/E. Merck OHG ; Case 2- Daiichi-Ranbaxy Acquisition Deal; Piramal Bought by Abbot Laboratories; Acquisition of Dabur Pharma Fresenus Kabi ; Shantha Biotech acquired; Chapter Five ; ..,/issues relating to patenting and compulsory licencing; Chapter Six; Right to access to medicine and pricing issues of Drug; Suggestions that can help to have better access to medicine; Price regulation of Drugs; The genericmedicine pricing & Competition ; Pricing of Vaccines ; Conclusion; Bibliography. |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dr. Sairam Bhat - GuideDr. Sairam Bhat - Guide |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://dans.nls.ac.in/handle/123456789/1951">https://dans.nls.ac.in/handle/123456789/1951</a> |
| Withdrawn status | Lost status | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | 09.02.2026 | LLM401 | 09.02.2026 | 09.02.2026 | Dissertation |